UTRN and Duchenne muscular dystrophy: For gene therapy of DMD, increasing the 100–200 bp 5′UTR motif can increase the expression of mini/micro-utrophin by enhancing the translation level on the basis of the improved transcription level of saRNA, which provides a powerful means to balance the safe dose with significant efficacy.